Table 2 IC50s for human and canine osteosarcoma cell lines treated with doxorubicin or carboplatin ± taurolidine (inhibition curves shown in Figure 2 A and 2 B)
Cell line | Doxorubicin (nM) | Doxorubicin (nM) + 20 μM Taurolidine | Carboplatin (μM) | Carboplatin (μM) + 20 μM Taurolidine | Carboplatin (μM) + 100 μM Taurolidine |
|---|---|---|---|---|---|
Saos-2 | 252 | 22 | 198 | 204 | 0 |
D17 | 100 | 12 | 414 | 202 | 0 |
Clone-4 | NR | 4 | 538 | 134 | 0 |